Juvenile-onset recurrent respiratory papillomatosis (JORRP)- Monitoring Juvenile Onset Recurrent Respir

The contract involves monitoring Juvenile-onset recurrent respiratory papillomatosis (JORRP), a condition characterized by the recurrent growth of benign tumors in the respiratory tract, typically affecting children. The work is being overseen by the Centers for Disease Control and Prevention (CDC) and aims to improve understanding and management of this rare but potentially serious disease. Although specific procurement details such as the solicitation number, set-aside status, or NAICS code are not provided, the contract forecast indicates the CDC’s interest in ongoing surveillance and data collection related to JORRP. This effort is part of a broader public health initiative to monitor and respond to conditions impacting pediatric respiratory health. The CDC has designated program and contracting officers to manage communications and contract procurement, with contacts available for further inquiries. The contract's place of performance and exact operational details remain unspecified, but the forecast suggests future opportunities to participate in research or monitoring activities addressing JORRP, aligning with the agency’s mission to protect public health through disease tracking and prevention.